Clinical trial NCT04379596 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-01 → 2027-05-04 3. primary completion date: 2027-06-01 → 2027-05-04 4. enrollment: 450 → 452 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07110376 updates: 1. completion date: 2026-12-31 → 2027-03-31 2. primary completion date: 2026-07-01 → 2026-12-31
Clinical trial NCT06152042: status: TERMINATED → COMPLETED.
Clinical trial NCT07196722: completion date: 2032-10-06 → 2032-10-10.
Clinical trial NCT07214272 updates: 1. completion date: 2026-09-01 → 2026-10-06 2. primary completion date: 2026-05-20 → 2026-08-24
Clinical trial NCT06132958 updates: 1. collaborators added: European Network of Gynaecological Oncological Trial Groups (ENGOT) 2. collaborators removed: European Network for Gynaecological Oncological Trial groups(ENGOT)
Clinical trial NCT04644770: completion date: 2026-12-08 → 2026-12-30.
Clinical trial NCT07716098: start date: 2026-07-27 → 2026-07-23.
Clinical trial NCT04023552 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-07-16 3. primary completion date: 2026-06-30 → 2026-07-16
Clinical trial NCT07782450: start date: 2026-08-16 → 2026-09-10.
Clinical trial NCT06385080: completion date: 2032-12-27 → 2033-07-28.
Clinical trial NCT04357821 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2025-06-12 3. primary completion date: 2026-06-01 → 2024-01-29
SuperX Secures First Batch of 128 Units of NVIDIA B300 AI Server Purchase Order from Ezisight, Marking Its Official Entry into the Australian Market